(Q37204336)

18 August 2017

1 reference

title

Guidelines for the management of basal cell carcinoma (English)

1 reference

British Association of Dermatologists

18 August 2017

author

series ordinal

4

object named as

British Association of Dermatologists

1 reference

18 August 2017

N R Telfer

1

1 reference

18 August 2017

G B Colver

series ordinal

2

1 reference

18 August 2017

C A Morton

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

British Journal of Dermatology

18 August 2017

published in

1 reference

18 August 2017

volume

159

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

35-48

1 reference

Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A systematic review of treatment modalities for primary basal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Prediction of Subclinical Tumor Infiltration in Basal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Metastatic basal cell carcinoma: report of two cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Variations in registration of skin cancer in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Skin cancer incidence and the ageing population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Trends in the presentation and treatment of basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Environmental risk factors predisposing to the development of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Nevoid basal cell carcinoma (Gorlin) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Dermoscopic pattern of pigmented basal cell carcinoma, blue-white variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Orbital invasion by periocular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma. Identification and treatment of the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Current modalities and new advances in the treatment of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Guidelines for the management of basal cell carcinoma. British Association of Dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Craniofacial resection for nonmelanoma skin cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Little evidence available on treatments for basal cell carcinoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Use of frozen section analysis in the treatment of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Surgical treatment of basal cell carcinomas using standard postoperative histological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Curative and aesthetic results of surgical treatment of 138 basal-cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Do basal cell carcinomas recur after complete conventional surgical excision?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Surgical margins for basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Incomplete excision of basal cell carcinomas: a retrospective audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Surgical management of incompletely excised basal cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Positive surgical excision margins of a basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The significance of incomplete excision in patients with basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A management approach to incompletely excised basal cell carcinomas of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Recurrent basal cell carcinoma after incomplete resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The significance of tumor persistence after incomplete excision of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Chemosurgery for skin cancer: fixed tissue and fresh tissue techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs' micrographic surgery for basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Surgery for basal-cell carcinoma of the face.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The incidence of major complications from Mohs micrographic surgery performed in office-based and hospital-based settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Tissue repair after Mohs surgery. A plastic surgeon's view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs micrographic surgery and the otolaryngologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Oculoplastic reconstruction following Mohs surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Periocular Mohs micrographic surgery: Results of a dual-site day-surgery service

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs' surgery of periocular basal cell carcinoma using formalin-fixed sections and delayed closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Management of periocular basal cell carcinoma with modified en face frozen section controlled excision

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Peripheral in-continuity tissue examination: a modification of Mohs' micrographic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Staged operations for basal cell carcinoma of the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Small margin excision of periocular basal cell carcinoma: 5 year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Small margin (2 mm) excision of peri-ocular basal cell carcinoma with delayed repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs micrographic surgery: a cost analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Mohs' micrographic surgery for basal-cell carcinoma of the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Curettage, electrosurgery and skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Treatment of basal cell carcinoma with curettage alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Treatment of basal cell carcinoma by dermatologists in the United Kingdom. British Association of Dermatologists Audit Subcommittee and the British Society for Dermatological Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma on the lower extremity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Recurrence Rates of Treated Basal Cell Carcinomas: Part 2: Curettage-Electrodesiccation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Failure of curettage and electrodesiccation for removal of basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Statistical data on malignant tumors in cryosurgery: 1982.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Fractional cryosurgery. A new technique for basal cell carcinoma of the eyelids and periorbital area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Histologic cure of basal cell carcinoma treated with cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cryosurgery for skin cancer: 30-year experience and cure rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cryosurgery in difficult to treat basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Recurrent basal cell carcinoma treated with cryosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A reappraisal of cryosurgery for eyelid basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma of the lip treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Radiotherapy of skin carcinomas of the pinna: a study of 115 lesions in 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

High incidence of second basal cell skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Follow-up of basal cell carcinomas: an audit of current practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

Basal cell carcinoma follow-up practices by dermatologists: a national survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08666.X

10.1111/J.1365-2133.2008.08666.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference